ANEMIA IN
PREGNANCY
Dr Rohayati bt. Mohd Baharin
1
Content
 Introduction
 Causes of Anemia
 Clinical Features and complication
 Investigations
 IDA
 Management
2
What is Anemia?
 Disorder by which the body is depleted of
RBC to carry adequate oxygen to tissues
 In pregnant lady normal Haemoglobin level is
≥ 11 gm%
 Anemic women is unable to tolerate an
equivalent amount of blood loss as those
without anemia.
3
ANEMIA
A BALANCE OF BOTH PRODUCTION AND LOSS!
INTRODUCTION
 Most common medical disorder in
pregnancy
 Affects nearly ½ of all pregnant
women in the world 1
 52% in developing countries
 23% in the developed world
 High demand for iron and other vitamins is increased
due to physiological burden of pregnancy.
 Due to inability to meet the required level for these
substances either as a result of dietary deficiencies or
infection 2
1. WHO database 1998-2005
2. Van den Broek N. The Cytology of Anaemia in Pregnancy in West
Africa Tropical Doctor. 1996;26:5–7
Local study reported that
 The overall prevalence of anemia 35% (SE 0.02) if
the cut off level is 11 g/dL and 11 % (SE 0.03) if the
cut-off level is 10 g/dL.
 The majority was of the mild type.
 The prevalence was higher in the teenage group, Indians
followed by Malays and Chinese
 Grandmultiparas and from urban residence are at risk too
Jamaiyah Hanif et al - Asia Pac J Clin Nutr
2007;16 (3):527-536
PHYSIOLOGICAL CHANGES
IN PREGNANCY
Blood volume begins to increase in week 6 of
gestation and reaches approximately 50% more
at 3rd trimester
Red cell mass increases as much as 25%
above pre-pregnancy levels
The plasma volume increase is proportionally
greater than the increase in red blood cell
mass resulting haemodilution
 Severe anaemia is associated increased risk of maternal
and child mortality
Population group Prevalence of anaemia Population affected
Percent 95% CI Number (million) 95% CI
Preschool-age children 47.4 45.7–49.1 293 283–303
School-age children 25.4 19.9–30.9 305 238–371
Pregnant women 41.8 39.9–43.8 56 54–59
Non-pregnant women 30.2 28.7–31.6 468 446–491
Men 12.7 8.6–16.9 260 175–345
Elderly 23.9 18.3–29.4 164 126–202
Total population 24.8 22.9–26.7 1620 1500–1740
Global anaemia prevalence and number of individuals
affected
Worldwide prevalence of anaemia 1993-2005
–WHO report 2007
C DIAGNOSIS
PHYSIOLOGICAL ANAEMIA
OLOGICAL ANAEMIA
 Hb = 10 gm%
 RBC = 3.2 million/mm3
 PCV = 30%
 Peripheral smear showing normal
morphology
HAEMATOLOGICAL
CHANGES
Elevated erythropoietin levels increase the total
red cell mass by the end of the second trimester
but haemoglobin concentrations never reach
pre-pregnancy levels.
A normal pregnancy creates a demand for about
1000 mg of additional iron.(60 mg elemental
iron or 300 mg ferrous sulfate per day).
Serum iron falls during pregnancy whilst
transferrin and total iron binding capacity rise.
IRON REQUIREMENT IN
PREGNANCY
 Maternal req. of total Iron -1000mg
 500 mg  Maternal Hb. Mass expansion
 300 mg  Fetus & Placenta
 200mg  Shed through gut., urine & skin
 2.5mg /day in early pregnancy
 5.5mg /day from 20 -32 weeks
Average 4 mg/
day
 6 – 8 mg/ day after 32 weeks
 Increases from 1-2mg in 1st trimester to 6-8 mg in 3rd trimester
Absorption of iron depends upon
a) Amount of iron in the diet
b) Bioavailability of iron
c) Physiological requirements
CLINICAL FEATURES OF
ANAEMIA
SYMPTOMS
 Fatigue
 Weakness
 Headache
 Loss of appetite
 Dysphagia
 Palpitations
 Dyspnea on exertion
SIGNS
 Glossitis
 Stomatitis
 Heart murmurs
 Increased JVP
 Tachycardia
 Tachypnea
 Postural hypotension
 Pallor
 Dryness or roughnessof the skin
 Koilonychia
 Dry & cracked lips & Brittle hair
AETIOLOGY OF ANAEMIA
Physiological
Acquire
 Iron deficiency anaemia (IDA)
 Nutritional deficiency – miconutrient deficiency
B12,Folate,Riboflavin, copper
 Chronic infection – TB,
 Inflammatory – SLE, RA, multiple myeloma
 Blood loss – GIT bleeding, abnormal uterine bleeding
 Blood disorder
 Abnormal RBC synthesis - Haemoglobinopathies
 Excessive RBC destruction - BM depression
 Others - malignancy
EFFECT ANAEMIA TO
PREGNANCY OUTCOME
 Preterm delivery (Scholl et al, 1994)
 Low birth weight (Cogswell et al, 2003)
 Placental abruption and increased peripartum
blood loss (Arnold et al, 2009).
Complications IF Untreated
 PPH  HYPOVOLEMIC SHOCK!
 HEART FAILURE
 FETAL IUGR
 INCREASED RISK OF INFECTION
 DELAY WOUND HEALING
INVESTIGATIONS
Basic
investigations
 Full blood count
 BFMP
 Stool ova & cysts
Specific test
 Peripheral blood film
 Total Iron Study
 Total Iron binding capacity
 Total ferritin
 Total transferrin
 Vitamins assay
 Folic acid
 Vitamin B1, B12
 Ascorbic acid
 Hb Electrophoresis
 Bone marrow aspiration
 Lupus anticoagulant antibody
 Rheumatoid factor antibody
 LE cells
 Others – LFT,Renal profile sputum
AFB
Normal red cell morphology
Hyperchromic Hypochromic
Macrocytic Microcytic
IDA
Target cells
Sickle cells
Poikiolocytosis
Stomatocytes
Acanthocytes
Ovalocyte Spherocytes Nucleated RBC
IRON RICH FOODS
 Dark-green leafy vegetables, such as
watercress and curly kale
 Iron-fortified cereals wholegrain eg brown rice
 Beans, peas, soya bean
 Nuts, peanut butter
 Meat and fish
 Oatmeal
 Spinach
 Apricots
 prunes
 Raisins
IRON ABSORPTION
 Occurs predominantly in the
duodenum and upper jejunum
 Whatever the mechanism of iron
uptake, normally only about 10%
of the elemental iron entering the
duodenum is absorbed.
 Absorption increases markedly
with iron deficiency
 In contrast, iron overload reduces
but does not eliminate absorption
 Physiologic iron requirements are 3 times higher
in pregnancy 1
 Approximately 1200 mg must be acquired from
the body iron store or diet
 Approximately 15% of dietary iron is absorbed
 Additional iron requirement reaches a peak toward
the end of 3rd trimester 4-6 mg/day. 2
 The additional iron is derived from both the stores
and increased absorption
1. Bothwell, T.H. (2000) American Journal Clinical Nutrition 72, 257S-264S
2. Tapiero, H., Gaté, L., Tew, K.D. (2001) Biomedicine and Pharmacotherapy 55,
324-332
 The serum ferritin level is the best measure of the
size of iron stores ( non-pregnant storage~ 300mg)
 During pregnancy estimated calculated Fe storage
is 800 mg ( the average woman must absorb 500
mg more iron)
 With adequate iron stores, less absorption of iron
require during the first trimester.
 Absorption is accelerated only after there has been
a substantial fall in the size of the iron store
Week of
gestation HB (g/L)
Serum
ferritin
(μg/L)
Iron
store2
(mg)
Absorptio
n (%)
12 127 43.8 350 7.2
24 116 11.1 88 36.3
36 116 5.4 43 66.1
IRON ABSORPTION IN
PREGNANCY
Data from Barrett et al. (1994).
Prevent Iron absorption
 Tea and coffee
 Calcium, found in dairy products
such as milk
 Antacids (medication to help relieve
indigestion)
 Proton pump inhibitors (PPIs), which affect the
production of acid in your stomach
 Some wholegrain cereals
contained phytic acid
Lagi oriii…..
MANAGEMENT OF ANAEMIA
IN PREGNANCY
 MEDICAL
 Iron and vitamin supplement
 Parenteral iron
 Others – depends on aetiology
 OBSTETRIC
 Antepartum
 Intrapartum
 Postpartum
Management
For purposes of management, the following
classification of anaemia can be used.
(WHO. 1992)
Management of anemia in pregnant mother with
thalassemia minor is according to severity of anaemia.
29
Severe anaemia Haemoglobin < 7 gm%
Moderate anaemia Haemoglobin 7 – < 9gm%
Mild anaemia Haemoglobin 9 – < 11gm%
IRON DEFICIENCY ANEMIA
 Commonest anemia in pregnancy
 Physiological iron requirements are 3x higher
in pregnancy, with increasing demand as
pregnancy advances
 Inadequate dietary supplement
 Ineffective absorption
 Increased iron loss
DIAGNOSIS OF IRON
DEFICIENCY ANAEMIA
 Low haemoglobin
 Low serum ferritin < 12 mcg/dl
 Microcytic & hypochromic in the
absence of
chronic diseases / haemoglobinopathies
 Low serum iron content (< 30mcg/dL)
 Low PCV, MCV, MCH, MCHC
 High TIBC > 400 mcg/dl
Haemoglobin
( g/dl)
Diagnosis
1 > 12 > 11 Normal, IDA excluded
2 < 12 > 11 Storage iron depletion
3 < 12 < 11 Iron deficiency anaemia
4 > 12 < 11 Other causes of anaemia
Categorization of women using
Haemoglobin and serum ferritin
TREATMENT OF IRON
DEFICIENCY ANAEMIA
Full blood count and MCV value is
considered a good screening tool
for IDA
Mild-moderate 70–100μg/L
Severe type < 20–30μg/L
Many patients do not respond adequately to oral
iron therapy due to:
ingestion
Side effects
HOW TO TAKE IRON
TABLETS?
35
Indication of parenteral iron
 Cannot tolerate side effects of oral iron
 Suffers from inflammatory bowel disease
 Patient does not comply
 Patient near term
TYPE OF PARENTERAL IRON
 Intravenous preparation
 Iron (II) hydroxide dextran ( Imferon )
 Iron (III) hydroxide dextran ( Cosmofer)
 Iron sucrose (Venofer)
 Intramuscular preparation
 Iron (II or III ) Dextran type
Iron dextran: 50 mg/mL.
Iron sucrose: 20 mg/mL.
Ferric gluconate: 12.5 mg/mL
INDICATION FOR
PARENTERAL IRON
 Failure to oral iron therapy.
 Non compliance/intolerance to oral iron
 1st time seen during last 8-10 wks with severe anemia
 Mal-absorbtion/IBD
 Small bowel resection
 When hemorrhage is likely to continue
 Contraindication to oral or blood transfusion
 Combination with recombinant human erythropoietin
CONTRAINDICATION PARENTERAL
IRON
 History of anaphylaxis to parenteral iron therapy
 1st trimester of pregnancy
 Active acute/chronic infection
 Chronic liver diseases
ADVANTAGES :
 Certainty of admission.
 Hb rises @1gm/wk.
DISADVANTAGES :
 Nausea and Vomiting
 Metallic taste on
tongue
Blood transfusion ????
 Should be avoided unless indicated
 Indication
Severely ( asymptomatic ) Hb < 6
gm% not in failure not responsive to
parenteral iron
Severe anaemia with heart failure
Hb < 8 gm % at term or in early
labour
Actively antepartum/postpartum
bleeding
Recommendation for IDA
 Iron supplementation decreases the prevalence of
maternal anemia at delivery. LEVEL A
 IDA associated with an increased risk of low birth
weight, preterm delivery, and perinatal mortality.
 Severe anaemia with maternal Hb ≤ 6 g/dL
associated with
abnormal fetal oxygenation
non-reassuring fetal heart rate patterns
reduced amniotic fluid volume,
fetal cerebral vasodilatation
fetal death. LEVEL B
.
ACOG July 2008 (ACOG practice bulletin; no. 95).
 All pregnant women should be screened for anemia
 Those with IDA should be treated with supplemental iron,
in addition to prenatal vitamins.
 Patients with anemia other than iron deficiency anemia
should be further evaluated.
 Failure to respond to iron therapy should prompt further
investigation and may suggest
incorrect diagnosis
coexisting disease
malabsorption noncompliance
blood loss LEVEL C
Anemia in pregnancy. American College of Obstetricians and
Gynecologists (ACOG); 2008 Jul. 7 p. (ACOG practice bulletin;
no. 95).
ANTENATAL MANAGEMENT
 Routine screening of anaemia
 For prophylaxis with Hb> 11 gm% , iron and vitamin
supplement to be taken weekly basis
 If Hb < 11gm%, Ferrous fumurate 200 mg bd on daily
basis
 Elemental iron dose content per tablet
Preparation Elemental iron (mg/tablet)
Fe fumurate 200mg 60 mg
Fe gluconate 250 mg
(Iberet)
105 mg
Fe sulphate (Obimin) 30 mg
MANAGEMENT OF OTHER
TYPE OF ANAEMIA
 Chronic diseases eg PTB, Renal diseases, connective
tissue diseases (SLE,RA)
 Haemolytic anaemia
 Aplastic anaemia
 Bone marrow diseases
Multidisciplinary approach and
treatment depend on the
causative factors
OBSTETRIC MANAGEMENT :
1. FETAL ASSESSMENT
Fundal height
Serial symphysio-fundal height
 Ultrasonograph for fetal
growth
OBSTETRIC MANAGEMENT :1. FETAL
ASSESSMENT
 Doppler studies
2. TIME AND MODE OF
DELIVERY
 In the absence of fetal or maternal complication
 Aim for vaginal delivery
 Wait for spontaneous onset of labor
 Induction of labour in the presence of obstetric
indications
 Optimise maternal health prior to labour
 Correct anaemia before elective delivery
3. ANAEMIA IN LABOUR
To transfuse if Hb< 8 gm% and transfer to
hospital with specialist
Blood taken GXM at least 2 units and
transfusion require
In the event of advance labour where transfer is
not possible, specialist input is require regarding
the need for transfusion
Oxytocin prophylactically postpartumlly with
pitocin infusion 40 unit at 40 drops/min for 4-8
hours
4. POSTNATAL PERIOD
 Continue oral iron supplement if Hb> 7 gm%
 Parenteral iron indicated if Hb bet 6-7 gm% provided
asymptomatic and not in heart failure
 Blood transfusions may be inappropriate in the
absence of continued / massive bleeding
 Dietary and Contraception advise
 Once the Hb is in the normal range,
treatment continued for 3 months
and at least until 6 weeks postpartum
to replenish iron stores
1. Parker, J., Thompson, J., Stanworth, S. (2009) International
Journal of Obstetric Anesthesia 18, 309-313
Severity of
Anemia
Hb level
(g/dL)
Management according period of
gestation (weeks
<12 12-28 29-35 ≥ 36
Normal (white
tag)
≥ 11gm% Heamatinic supplement
(to be taken weekly)
- Ferrous fumarate 400 mg
- Folic 5 mg
- Vitamin Bco 1 tablet
- Vitamin C 100 mg
Option: - Other preparation of supplement
52
Severity of
Anemia
Hb level
(g/dL)
Management according period of gestation
(weeks
<12 12-28 29-35 ≥ 36
Mild (green tag) 9.0 –
<11.0
Asymptomatic
Lab Investigation: -
- Full blood count
- Stool ova and cyst (Optional)
Haematinics
- Ferrous fumarate 400 mg daily/200 mg bd
- Folic 5 mg daily
- Vitamin Bco 1 tab daily
- Vitamin C 100 mg daily
Option: Other preparation of supplement
Refer to MO & HO for assessment. If patient is
anemic and symptomatic on follow up, refer to
FMS.
53
Severity of
Anemia
Hb level
(g/dL)
Management according period of
gestation (weeks
<12 12-28 29-35 ≥ 36
Moderate (yellow
tag)
7.0 –
<9.0 gm%
Laboratory investigation:
- Peripheral blood film (PBF)
- Serum Ferritin
- TIBC
- Serum folate and Vitamin B12 if blood film
suggest macrocytic anaemia
- Hb electrophoresis if haemoglobinopathy
is suspected
- BFMP (if indicated)
- Stool ova and cyst (optional)
*Repeat FBC 2 weekly.
54
Severity of
Anemia
Hb level
(g/dL)
Management according period of
gestation (weeks
<12 12-28 29-35 ≥ 36
Moderate (yellow
tag)
7.0 –
<9.0 gm%
Haematinics
Ferrous fumarate
400 mg bd
Folic 5 mg daily
Vitamin Bco 1 tab
daily
Vitamin C 100 mg
daily
Option:
Other preparation
of supplement
Continue oral
heamatinics
If poor
compliance, not
tolerating orally or
fail to increase
Hb level. Patient
should be
counselled for
parenteral
treatment. (option
I/M or I/V)
If patient
symptomatic
refer hospital
Refer to
Hospital.
55
Severity of
Anemia
Hb level
(g/dL)
Management according period of gestation
(weeks
<12 12-28 29-35 ≥ 36
Severe
(red tag)
< 7.0
gm%
Refer to
Hospital
Refer to
Hospital
Refer to
Hospital
Refer to
Hospital
56
Moderate Anemia
 Patients with Hb between 7 – <9 gm%.
 Full blood count should be performed and patient counseled
regarding diet and hematinics
 If the patient is not reliable or is unable to tolerate oral
therapy, iron dextran therapy is indicated either by
intramuscular injection or by IV infusion in divided doses.
 Iron dextran therapy by intramuscular injection can be
given in the health clinic, after test dose 0.5ml given by a
Medical Officer. During this therapy, oral iron should be
omitted.
 After the completion of iron dextran therapy, oral hematinics
may be continued. Reassess patients’ general condition
and haemoglobin level 2 weeks later.
 Cases which do not respond to treatment should be referred
to FMS/ hospital for further management.
57
Severe Anemia
 Patient with Hb < 7 gm% *Refer case to hospital for
management
 Assess the patient for reliability and compliance.
 If the patient is asymptomatic and compliant to all
medications before 32 weeks, oral therapy is sufficient.
 If the patient is asymptomatic and not compliant to all
medications after 2nd trimester, parenteral iron (Iron
Sucrose or Dextran) is indicated.
 If the patient is symptomatic and clinically pale, blood
transfusion is necessary.
NOTE: All cases of cardiac failure and intrauterine
growth retardation must be referred to hospital for
further management.
58
Dextran
 Formula to calculate the amount of iron dextran to
be given:
(Normal Hb – patient’s Hb in gm%) x body weight (kg) x factor*
+ 500 mg = ______ mg of elemental iron
 One ampoule of iron dextran (2ml) contains 50 mg of
elemental iron per ml (100 mg).
 Test Dose IM 0.5ml (undiluted solution) to be given
by a doctor in the hospital or clinic (with adequate
resuscitation equipment). Iron dextran to be given
under supervision by doctor.
*factor - for iron dextran = 0.24 (*Factors vary depend
- for iron sucrose = 2.4 on drug preparation)
59
THANK YOU
FOR YOUR ATTENTION

Anemia in pregnancy safemotherhood

  • 1.
  • 2.
    Content  Introduction  Causesof Anemia  Clinical Features and complication  Investigations  IDA  Management 2
  • 3.
    What is Anemia? Disorder by which the body is depleted of RBC to carry adequate oxygen to tissues  In pregnant lady normal Haemoglobin level is ≥ 11 gm%  Anemic women is unable to tolerate an equivalent amount of blood loss as those without anemia. 3
  • 4.
    ANEMIA A BALANCE OFBOTH PRODUCTION AND LOSS!
  • 5.
    INTRODUCTION  Most commonmedical disorder in pregnancy  Affects nearly ½ of all pregnant women in the world 1  52% in developing countries  23% in the developed world  High demand for iron and other vitamins is increased due to physiological burden of pregnancy.  Due to inability to meet the required level for these substances either as a result of dietary deficiencies or infection 2 1. WHO database 1998-2005 2. Van den Broek N. The Cytology of Anaemia in Pregnancy in West Africa Tropical Doctor. 1996;26:5–7
  • 6.
    Local study reportedthat  The overall prevalence of anemia 35% (SE 0.02) if the cut off level is 11 g/dL and 11 % (SE 0.03) if the cut-off level is 10 g/dL.  The majority was of the mild type.  The prevalence was higher in the teenage group, Indians followed by Malays and Chinese  Grandmultiparas and from urban residence are at risk too Jamaiyah Hanif et al - Asia Pac J Clin Nutr 2007;16 (3):527-536
  • 7.
    PHYSIOLOGICAL CHANGES IN PREGNANCY Bloodvolume begins to increase in week 6 of gestation and reaches approximately 50% more at 3rd trimester Red cell mass increases as much as 25% above pre-pregnancy levels The plasma volume increase is proportionally greater than the increase in red blood cell mass resulting haemodilution
  • 9.
     Severe anaemiais associated increased risk of maternal and child mortality Population group Prevalence of anaemia Population affected Percent 95% CI Number (million) 95% CI Preschool-age children 47.4 45.7–49.1 293 283–303 School-age children 25.4 19.9–30.9 305 238–371 Pregnant women 41.8 39.9–43.8 56 54–59 Non-pregnant women 30.2 28.7–31.6 468 446–491 Men 12.7 8.6–16.9 260 175–345 Elderly 23.9 18.3–29.4 164 126–202 Total population 24.8 22.9–26.7 1620 1500–1740 Global anaemia prevalence and number of individuals affected Worldwide prevalence of anaemia 1993-2005 –WHO report 2007
  • 10.
    C DIAGNOSIS PHYSIOLOGICAL ANAEMIA OLOGICALANAEMIA  Hb = 10 gm%  RBC = 3.2 million/mm3  PCV = 30%  Peripheral smear showing normal morphology
  • 11.
    HAEMATOLOGICAL CHANGES Elevated erythropoietin levelsincrease the total red cell mass by the end of the second trimester but haemoglobin concentrations never reach pre-pregnancy levels. A normal pregnancy creates a demand for about 1000 mg of additional iron.(60 mg elemental iron or 300 mg ferrous sulfate per day). Serum iron falls during pregnancy whilst transferrin and total iron binding capacity rise.
  • 12.
    IRON REQUIREMENT IN PREGNANCY Maternal req. of total Iron -1000mg  500 mg  Maternal Hb. Mass expansion  300 mg  Fetus & Placenta  200mg  Shed through gut., urine & skin  2.5mg /day in early pregnancy  5.5mg /day from 20 -32 weeks Average 4 mg/ day  6 – 8 mg/ day after 32 weeks  Increases from 1-2mg in 1st trimester to 6-8 mg in 3rd trimester
  • 13.
    Absorption of irondepends upon a) Amount of iron in the diet b) Bioavailability of iron c) Physiological requirements
  • 14.
    CLINICAL FEATURES OF ANAEMIA SYMPTOMS Fatigue  Weakness  Headache  Loss of appetite  Dysphagia  Palpitations  Dyspnea on exertion SIGNS  Glossitis  Stomatitis  Heart murmurs  Increased JVP  Tachycardia  Tachypnea  Postural hypotension  Pallor  Dryness or roughnessof the skin  Koilonychia  Dry & cracked lips & Brittle hair
  • 15.
    AETIOLOGY OF ANAEMIA Physiological Acquire Iron deficiency anaemia (IDA)  Nutritional deficiency – miconutrient deficiency B12,Folate,Riboflavin, copper  Chronic infection – TB,  Inflammatory – SLE, RA, multiple myeloma  Blood loss – GIT bleeding, abnormal uterine bleeding  Blood disorder  Abnormal RBC synthesis - Haemoglobinopathies  Excessive RBC destruction - BM depression  Others - malignancy
  • 16.
    EFFECT ANAEMIA TO PREGNANCYOUTCOME  Preterm delivery (Scholl et al, 1994)  Low birth weight (Cogswell et al, 2003)  Placental abruption and increased peripartum blood loss (Arnold et al, 2009).
  • 17.
    Complications IF Untreated PPH  HYPOVOLEMIC SHOCK!  HEART FAILURE  FETAL IUGR  INCREASED RISK OF INFECTION  DELAY WOUND HEALING
  • 18.
    INVESTIGATIONS Basic investigations  Full bloodcount  BFMP  Stool ova & cysts Specific test  Peripheral blood film  Total Iron Study  Total Iron binding capacity  Total ferritin  Total transferrin  Vitamins assay  Folic acid  Vitamin B1, B12  Ascorbic acid  Hb Electrophoresis  Bone marrow aspiration  Lupus anticoagulant antibody  Rheumatoid factor antibody  LE cells  Others – LFT,Renal profile sputum AFB
  • 19.
    Normal red cellmorphology
  • 20.
  • 21.
  • 22.
    IRON RICH FOODS Dark-green leafy vegetables, such as watercress and curly kale  Iron-fortified cereals wholegrain eg brown rice  Beans, peas, soya bean  Nuts, peanut butter  Meat and fish  Oatmeal  Spinach  Apricots  prunes  Raisins
  • 23.
    IRON ABSORPTION  Occurspredominantly in the duodenum and upper jejunum  Whatever the mechanism of iron uptake, normally only about 10% of the elemental iron entering the duodenum is absorbed.  Absorption increases markedly with iron deficiency  In contrast, iron overload reduces but does not eliminate absorption
  • 24.
     Physiologic ironrequirements are 3 times higher in pregnancy 1  Approximately 1200 mg must be acquired from the body iron store or diet  Approximately 15% of dietary iron is absorbed  Additional iron requirement reaches a peak toward the end of 3rd trimester 4-6 mg/day. 2  The additional iron is derived from both the stores and increased absorption 1. Bothwell, T.H. (2000) American Journal Clinical Nutrition 72, 257S-264S 2. Tapiero, H., Gaté, L., Tew, K.D. (2001) Biomedicine and Pharmacotherapy 55, 324-332
  • 25.
     The serumferritin level is the best measure of the size of iron stores ( non-pregnant storage~ 300mg)  During pregnancy estimated calculated Fe storage is 800 mg ( the average woman must absorb 500 mg more iron)  With adequate iron stores, less absorption of iron require during the first trimester.  Absorption is accelerated only after there has been a substantial fall in the size of the iron store
  • 26.
    Week of gestation HB(g/L) Serum ferritin (μg/L) Iron store2 (mg) Absorptio n (%) 12 127 43.8 350 7.2 24 116 11.1 88 36.3 36 116 5.4 43 66.1 IRON ABSORPTION IN PREGNANCY Data from Barrett et al. (1994).
  • 27.
    Prevent Iron absorption Tea and coffee  Calcium, found in dairy products such as milk  Antacids (medication to help relieve indigestion)  Proton pump inhibitors (PPIs), which affect the production of acid in your stomach  Some wholegrain cereals contained phytic acid Lagi oriii…..
  • 28.
    MANAGEMENT OF ANAEMIA INPREGNANCY  MEDICAL  Iron and vitamin supplement  Parenteral iron  Others – depends on aetiology  OBSTETRIC  Antepartum  Intrapartum  Postpartum
  • 29.
    Management For purposes ofmanagement, the following classification of anaemia can be used. (WHO. 1992) Management of anemia in pregnant mother with thalassemia minor is according to severity of anaemia. 29 Severe anaemia Haemoglobin < 7 gm% Moderate anaemia Haemoglobin 7 – < 9gm% Mild anaemia Haemoglobin 9 – < 11gm%
  • 30.
    IRON DEFICIENCY ANEMIA Commonest anemia in pregnancy  Physiological iron requirements are 3x higher in pregnancy, with increasing demand as pregnancy advances  Inadequate dietary supplement  Ineffective absorption  Increased iron loss
  • 31.
    DIAGNOSIS OF IRON DEFICIENCYANAEMIA  Low haemoglobin  Low serum ferritin < 12 mcg/dl  Microcytic & hypochromic in the absence of chronic diseases / haemoglobinopathies  Low serum iron content (< 30mcg/dL)  Low PCV, MCV, MCH, MCHC  High TIBC > 400 mcg/dl
  • 32.
    Haemoglobin ( g/dl) Diagnosis 1 >12 > 11 Normal, IDA excluded 2 < 12 > 11 Storage iron depletion 3 < 12 < 11 Iron deficiency anaemia 4 > 12 < 11 Other causes of anaemia Categorization of women using Haemoglobin and serum ferritin
  • 33.
    TREATMENT OF IRON DEFICIENCYANAEMIA Full blood count and MCV value is considered a good screening tool for IDA Mild-moderate 70–100μg/L Severe type < 20–30μg/L Many patients do not respond adequately to oral iron therapy due to: ingestion Side effects
  • 35.
    HOW TO TAKEIRON TABLETS? 35
  • 36.
    Indication of parenteraliron  Cannot tolerate side effects of oral iron  Suffers from inflammatory bowel disease  Patient does not comply  Patient near term
  • 37.
    TYPE OF PARENTERALIRON  Intravenous preparation  Iron (II) hydroxide dextran ( Imferon )  Iron (III) hydroxide dextran ( Cosmofer)  Iron sucrose (Venofer)  Intramuscular preparation  Iron (II or III ) Dextran type Iron dextran: 50 mg/mL. Iron sucrose: 20 mg/mL. Ferric gluconate: 12.5 mg/mL
  • 38.
    INDICATION FOR PARENTERAL IRON Failure to oral iron therapy.  Non compliance/intolerance to oral iron  1st time seen during last 8-10 wks with severe anemia  Mal-absorbtion/IBD  Small bowel resection  When hemorrhage is likely to continue  Contraindication to oral or blood transfusion  Combination with recombinant human erythropoietin
  • 39.
    CONTRAINDICATION PARENTERAL IRON  Historyof anaphylaxis to parenteral iron therapy  1st trimester of pregnancy  Active acute/chronic infection  Chronic liver diseases ADVANTAGES :  Certainty of admission.  Hb rises @1gm/wk. DISADVANTAGES :  Nausea and Vomiting  Metallic taste on tongue
  • 40.
    Blood transfusion ???? Should be avoided unless indicated  Indication Severely ( asymptomatic ) Hb < 6 gm% not in failure not responsive to parenteral iron Severe anaemia with heart failure Hb < 8 gm % at term or in early labour Actively antepartum/postpartum bleeding
  • 41.
    Recommendation for IDA Iron supplementation decreases the prevalence of maternal anemia at delivery. LEVEL A  IDA associated with an increased risk of low birth weight, preterm delivery, and perinatal mortality.  Severe anaemia with maternal Hb ≤ 6 g/dL associated with abnormal fetal oxygenation non-reassuring fetal heart rate patterns reduced amniotic fluid volume, fetal cerebral vasodilatation fetal death. LEVEL B . ACOG July 2008 (ACOG practice bulletin; no. 95).
  • 42.
     All pregnantwomen should be screened for anemia  Those with IDA should be treated with supplemental iron, in addition to prenatal vitamins.  Patients with anemia other than iron deficiency anemia should be further evaluated.  Failure to respond to iron therapy should prompt further investigation and may suggest incorrect diagnosis coexisting disease malabsorption noncompliance blood loss LEVEL C Anemia in pregnancy. American College of Obstetricians and Gynecologists (ACOG); 2008 Jul. 7 p. (ACOG practice bulletin; no. 95).
  • 43.
    ANTENATAL MANAGEMENT  Routinescreening of anaemia  For prophylaxis with Hb> 11 gm% , iron and vitamin supplement to be taken weekly basis  If Hb < 11gm%, Ferrous fumurate 200 mg bd on daily basis  Elemental iron dose content per tablet Preparation Elemental iron (mg/tablet) Fe fumurate 200mg 60 mg Fe gluconate 250 mg (Iberet) 105 mg Fe sulphate (Obimin) 30 mg
  • 44.
    MANAGEMENT OF OTHER TYPEOF ANAEMIA  Chronic diseases eg PTB, Renal diseases, connective tissue diseases (SLE,RA)  Haemolytic anaemia  Aplastic anaemia  Bone marrow diseases Multidisciplinary approach and treatment depend on the causative factors
  • 45.
    OBSTETRIC MANAGEMENT : 1.FETAL ASSESSMENT Fundal height Serial symphysio-fundal height
  • 46.
     Ultrasonograph forfetal growth OBSTETRIC MANAGEMENT :1. FETAL ASSESSMENT
  • 47.
  • 49.
    2. TIME ANDMODE OF DELIVERY  In the absence of fetal or maternal complication  Aim for vaginal delivery  Wait for spontaneous onset of labor  Induction of labour in the presence of obstetric indications  Optimise maternal health prior to labour  Correct anaemia before elective delivery
  • 50.
    3. ANAEMIA INLABOUR To transfuse if Hb< 8 gm% and transfer to hospital with specialist Blood taken GXM at least 2 units and transfusion require In the event of advance labour where transfer is not possible, specialist input is require regarding the need for transfusion Oxytocin prophylactically postpartumlly with pitocin infusion 40 unit at 40 drops/min for 4-8 hours
  • 51.
    4. POSTNATAL PERIOD Continue oral iron supplement if Hb> 7 gm%  Parenteral iron indicated if Hb bet 6-7 gm% provided asymptomatic and not in heart failure  Blood transfusions may be inappropriate in the absence of continued / massive bleeding  Dietary and Contraception advise  Once the Hb is in the normal range, treatment continued for 3 months and at least until 6 weeks postpartum to replenish iron stores 1. Parker, J., Thompson, J., Stanworth, S. (2009) International Journal of Obstetric Anesthesia 18, 309-313
  • 52.
    Severity of Anemia Hb level (g/dL) Managementaccording period of gestation (weeks <12 12-28 29-35 ≥ 36 Normal (white tag) ≥ 11gm% Heamatinic supplement (to be taken weekly) - Ferrous fumarate 400 mg - Folic 5 mg - Vitamin Bco 1 tablet - Vitamin C 100 mg Option: - Other preparation of supplement 52
  • 53.
    Severity of Anemia Hb level (g/dL) Managementaccording period of gestation (weeks <12 12-28 29-35 ≥ 36 Mild (green tag) 9.0 – <11.0 Asymptomatic Lab Investigation: - - Full blood count - Stool ova and cyst (Optional) Haematinics - Ferrous fumarate 400 mg daily/200 mg bd - Folic 5 mg daily - Vitamin Bco 1 tab daily - Vitamin C 100 mg daily Option: Other preparation of supplement Refer to MO & HO for assessment. If patient is anemic and symptomatic on follow up, refer to FMS. 53
  • 54.
    Severity of Anemia Hb level (g/dL) Managementaccording period of gestation (weeks <12 12-28 29-35 ≥ 36 Moderate (yellow tag) 7.0 – <9.0 gm% Laboratory investigation: - Peripheral blood film (PBF) - Serum Ferritin - TIBC - Serum folate and Vitamin B12 if blood film suggest macrocytic anaemia - Hb electrophoresis if haemoglobinopathy is suspected - BFMP (if indicated) - Stool ova and cyst (optional) *Repeat FBC 2 weekly. 54
  • 55.
    Severity of Anemia Hb level (g/dL) Managementaccording period of gestation (weeks <12 12-28 29-35 ≥ 36 Moderate (yellow tag) 7.0 – <9.0 gm% Haematinics Ferrous fumarate 400 mg bd Folic 5 mg daily Vitamin Bco 1 tab daily Vitamin C 100 mg daily Option: Other preparation of supplement Continue oral heamatinics If poor compliance, not tolerating orally or fail to increase Hb level. Patient should be counselled for parenteral treatment. (option I/M or I/V) If patient symptomatic refer hospital Refer to Hospital. 55
  • 56.
    Severity of Anemia Hb level (g/dL) Managementaccording period of gestation (weeks <12 12-28 29-35 ≥ 36 Severe (red tag) < 7.0 gm% Refer to Hospital Refer to Hospital Refer to Hospital Refer to Hospital 56
  • 57.
    Moderate Anemia  Patientswith Hb between 7 – <9 gm%.  Full blood count should be performed and patient counseled regarding diet and hematinics  If the patient is not reliable or is unable to tolerate oral therapy, iron dextran therapy is indicated either by intramuscular injection or by IV infusion in divided doses.  Iron dextran therapy by intramuscular injection can be given in the health clinic, after test dose 0.5ml given by a Medical Officer. During this therapy, oral iron should be omitted.  After the completion of iron dextran therapy, oral hematinics may be continued. Reassess patients’ general condition and haemoglobin level 2 weeks later.  Cases which do not respond to treatment should be referred to FMS/ hospital for further management. 57
  • 58.
    Severe Anemia  Patientwith Hb < 7 gm% *Refer case to hospital for management  Assess the patient for reliability and compliance.  If the patient is asymptomatic and compliant to all medications before 32 weeks, oral therapy is sufficient.  If the patient is asymptomatic and not compliant to all medications after 2nd trimester, parenteral iron (Iron Sucrose or Dextran) is indicated.  If the patient is symptomatic and clinically pale, blood transfusion is necessary. NOTE: All cases of cardiac failure and intrauterine growth retardation must be referred to hospital for further management. 58
  • 59.
    Dextran  Formula tocalculate the amount of iron dextran to be given: (Normal Hb – patient’s Hb in gm%) x body weight (kg) x factor* + 500 mg = ______ mg of elemental iron  One ampoule of iron dextran (2ml) contains 50 mg of elemental iron per ml (100 mg).  Test Dose IM 0.5ml (undiluted solution) to be given by a doctor in the hospital or clinic (with adequate resuscitation equipment). Iron dextran to be given under supervision by doctor. *factor - for iron dextran = 0.24 (*Factors vary depend - for iron sucrose = 2.4 on drug preparation) 59
  • 60.